Blog

Pashtoon Kasi: Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal

Photo from Pashtoon Kasi / X

Dec 20, 2023, 09:57

Pashtoon Kasi: Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal

Pashtoon Kasi, the Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on X:

“Our paper with more than 10,000 accesses ranks at N1 in Oncogene Journal.

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient (pMMR/MSS) colorectal cancer.

Link: https://nature.com/articles/s41388-023-02835-y

GI24 will present full NEST-1 cohort.”

Source: Pashtoon Kasi / X

Balstilimab botensilimab botensilimab plus balstilimab cancer colorectal cancer Colorectal Cancer Research immunotherapy immunotherapy for colorectal cancer mismatch repair proficient Neoadjuvant botensilimab plus balstilimab OncoDaily Oncogene journal Oncology Pashtoon Kasi Weill Cornell Medicine

Senator John Fetterman Responds to Oncodaily on Pediatric Oncology Funding

Does Processed Meat Cause Cancer? Myths and Facts

Global Health Dialogues with Princess Dina Mired | Episode 1: Dr. Firas Al-Hawari

NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

Oncologist Near Me - Matti Aapro: Pioneering Excellence in Cancer Care and Geriatric Oncology